Soleus Capital Management’s CytomX Therapeutics CTMX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$2.96M	Buy	+1,304,300	New	+$2.96M	0.2%	68
2021 Q4	–	Sell	-261,050	Closed	-$1.33M	–	74
2021 Q3	$1.33M	Buy	+261,050	New	+$1.33M	0.21%	63